Report for: Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol

Title	Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol
Published in	Cochrane database of systematic reviews, June 2019
DOI	10.1002/14651858.cd013364
Authors	Zhen Zhu, Kexun Zhang, Ning Cai, Edward Charbek, Aaron C Miller, Sibo Zhu, Chen Suo, Xingdong Chen, Huan Song

View on publisher site Alert me about new mentions

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Unknown	5	100%

Demographic breakdown

Readers by professional status	Count	As %
Lecturer	1	20%
Student > Bachelor	1	20%
Professor	1	20%
Student > Master	1	20%
Researcher	1	20%
Other	0	0%

Readers by discipline	Count	As %
Biochemistry, Genetics and Molecular Biology	1	20%
Immunology and Microbiology	1	20%
Economics, Econometrics and Finance	1	20%
Social Sciences	1	20%
Medicine and Dentistry	1	20%
Other	0	0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2019.

All research outputs

#20,575,461

of 23,152,542 outputs

Outputs from Cochrane database of systematic reviews

#12,057

of 12,383 outputs

Outputs of similar age

#298,153

of 350,952 outputs

Outputs of similar age from Cochrane database of systematic reviews

#175

of 180 outputs

Altmetric has tracked 23,152,542 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.

So far Altmetric has tracked 12,383 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,952 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.

We're also able to compare this research output to 180 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.

Cochrane Database of Systematic Reviews

Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol

Mentioned by

Citations

Readers on

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context